0.22
-0.0062(-2.79%)
Currency In USD
| Previous Close | 0.22 |
| Open | 0.21 |
| Day High | 0.22 |
| Day Low | 0.2 |
| 52-Week High | 4.71 |
| 52-Week Low | 0.2 |
| Volume | 1.52M |
| Average Volume | 4.46M |
| Market Cap | 2.37M |
| PE | -0.07 |
| EPS | -3.3 |
| Moving Average 50 Days | 0.35 |
| Moving Average 200 Days | 1.02 |
| Change | -0.01 |
If you invested $1000 in Shuttle Pharmaceuticals Holdings, Inc. (SHPH) since IPO date, it would be worth $0.7 as of May 18, 2025 at a share price of $0.216. Whereas If you bought $1000 worth of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) shares 2 years ago, it would be worth $26.15 as of May 18, 2025 at a share price of $0.216.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Shuttle Pharma Provides Corporate Update
GlobeNewswire Inc.
May 15, 2025 8:45 PM GMT
GAITHERSBURG, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for canc
Shuttle Pharma FDA Orphan-Drug Nears Patient Enrollment Milestone for Phase 2 Clinical Trial
GlobeNewswire Inc.
May 08, 2025 8:01 PM GMT
GAITHERSBURG, Md., May 08, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for canc
Shuttle Pharma to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025
GlobeNewswire Inc.
Apr 21, 2025 8:15 PM GMT
Company to conduct 1x1 meetings on April 24, 2025GAITHERSBURG, Md., April 21, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty pharmaceut